Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 4
2016 2
2017 4
2018 6
2019 9
2020 10
2021 8
2022 9
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Clinical promise of next-generation complement therapeutics.
Mastellos DC, Ricklin D, Lambris JD. Mastellos DC, et al. Nat Rev Drug Discov. 2019 Sep;18(9):707-729. doi: 10.1038/s41573-019-0031-6. Epub 2019 Jul 19. Nat Rev Drug Discov. 2019. PMID: 31324874 Free PMC article. Review.
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, Tektonidou M, Konstantinidis T, Papagoras C, Mitroulis I, Germanidis G, Lambris JD, Ritis K. Skendros P, et al. Among authors: mastellos dc. J Clin Invest. 2020 Nov 2;130(11):6151-6157. doi: 10.1172/JCI141374. J Clin Invest. 2020. PMID: 32759504 Free PMC article. Clinical Trial.
Novel mechanisms and functions of complement.
Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. Hajishengallis G, et al. Among authors: mastellos dc. Nat Immunol. 2017 Nov 16;18(12):1288-1298. doi: 10.1038/ni.3858. Nat Immunol. 2017. PMID: 29144501 Free PMC article. Review.
The renaissance of complement therapeutics.
Ricklin D, Mastellos DC, Reis ES, Lambris JD. Ricklin D, et al. Among authors: mastellos dc. Nat Rev Nephrol. 2018 Jan;14(1):26-47. doi: 10.1038/nrneph.2017.156. Epub 2017 Dec 4. Nat Rev Nephrol. 2018. PMID: 29199277 Free PMC article. Review.
C3-targeted host-modulation approaches to oral inflammatory conditions.
Kajikawa T, Mastellos DC, Hasturk H, Kotsakis GA, Yancopoulou D, Lambris JD, Hajishengallis G. Kajikawa T, et al. Among authors: mastellos dc. Semin Immunol. 2022 Jan;59:101608. doi: 10.1016/j.smim.2022.101608. Epub 2022 Jun 9. Semin Immunol. 2022. PMID: 35691883 Review.
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.
Skendros P, Germanidis G, Mastellos DC, Antoniadou C, Gavriilidis E, Kalopitas G, Samakidou A, Liontos A, Chrysanthopoulou A, Ntinopoulou M, Kogias D, Karanika I, Smyrlis A, Cepaityte D, Fotiadou I, Zioga N, Mitroulis I, Gatselis NK, Papagoras C, Metallidis S, Milionis H, Dalekos GN, Willems L, Persson B, Manivel VA, Nilsson B, Connolly ES, Iacobelli S, Papadopoulos V, Calado RT, Huber-Lang M, Risitano AM, Yancopoulou D, Ritis K, Lambris JD. Skendros P, et al. Among authors: mastellos dc. Sci Adv. 2022 Aug 19;8(33):eabo2341. doi: 10.1126/sciadv.abo2341. Epub 2022 Aug 17. Sci Adv. 2022. PMID: 35977025 Free PMC article.
Complement-Dependent Mechanisms and Interventions in Periodontal Disease.
Hajishengallis G, Kajikawa T, Hajishengallis E, Maekawa T, Reis ES, Mastellos DC, Yancopoulou D, Hasturk H, Lambris JD. Hajishengallis G, et al. Among authors: mastellos dc. Front Immunol. 2019 Mar 12;10:406. doi: 10.3389/fimmu.2019.00406. eCollection 2019. Front Immunol. 2019. PMID: 30915073 Free PMC article. Review.
51 results